is contracted via the University of Liverpool (no personal payment) to undertake consultancy for Altimmune, AstraZeneca, Boehringer Ingelheim, Cytoki, Eli Lilly, Napp, Novo Nordisk, Menarini, Pfizer, Rhythm Pharmaceuticals, Sanofi, Saniona, Tern Pharmaceuticals, Shionogi and Ysopia
It is structurally related to tuftsin, an immunomodulatory peptide that plays a role in improving the activity of immune cells such as macrophages and natural killer cells
What community sources describe: Self-reported community timelines describe earlier satiety and smaller portion sizes as the first noticeable change, often within the first one to two weeks
The role of tumourstromal interactions in modifying drug response: challenges and opportunities